Let's just look at one paper for a minute. Paper attached; I decree that these are indeed
educational purposes and the doctrine of fair use shall apply. Sue me, Elsevier.
http://onlinelibrary.wiley.com/doi/10.1002/nrc.20023/abstract
http://www.pdf-archive.com/2015/09/26/lsdmdmatransporterloss/ (full paper)
The argument is based on differences in optical density of the stained hippocampus under different drug treatments: control vs. MDMA vs. MDMA + LSD vs. MDMA + Glemanserin (MDL). The averaged optical density can be seen in Table 3. The first thing that sticks out at me is that MDMA + 2.5mg/kg MDL and MDMA + 5 mg/kg MDL show increasing optical density but MDMA + 7.5 mg/kg MDL shows a decrease resp. MDMA + 5 mg/kg MDL. As the other correlations are rather smooth, this outlier is particularly interesting.
The
other datapoint of note is that LSD alone causes an apparent decrease in the optical density of the stained hippocampus. Paired with other results about the apparent lack of long-term LSD neurotoxicity we may come away questioning the metric. But the real reason for this is in Fig 1 and Fig 2: there is a noticeable difference between Fig 1B (LSD only) and Fig 1A (control) as well as between Fig 2B (MDL only) and Fig 2A. In fact both LSD and MDL seem to make the hippocampus significantly darker to the eye, but on the chart this translates to a lower mean optical density.
In Fig. 6 we are left wondering whether MDL really had any effect after all, or if the apparent reduction of neurotoxicity seen with MDL 5 mg/kg was really just a coincidence. There is a sort of
"false-positive generation effect" that occurs when multiple regressions are run on the same dataset; it becomes probable that one will return a positive result.
But the correlation in Table 3 occurring between MDMA + 25 µg/kg;50 µg/kg;100 µg/kg LSD is indeed frightening to look at. To get an idea of how these translate to human doses, a 100 µg/kg dose of LSD in a 0.25 kg rat
allometrically scales with an exponent of 0.75 (normal stuff) to about 1700 µg LSD in a 70 kg human (if we assume the rat weighs 0.125 kg, the human equivalent is 1400 µg). That is, even the
smallest dose of LSD tested appears to be much larger (equivalent to ~425 µg) than a typical human dose, and the dose which produced truly concerning effects is in fact much larger than a typical human dose. It is not entirely unreasonable to suggest that since LSD is already rather unselective that at these dose levels many "side-effects" of LSD become prominent and may in fact be primarily responsible for the observed increase in neurotoxicity.
In summary, there are numerous methodological problems with this study, which may be why
it has only been cited once in eleven years since its publication. It makes one yearn for the '80s; they would have had the rats run in a maze and tried to measure cognitive effects, which are much more meaningful (to me) than some pretty pictures. I should say: I have really only scratched the surface in analyzing this; I have a job these days, it sucks but that's life.
But why do we care? Why should we complain about methodological flaws? If there's a potential risk, shouldn't users be cautioned to avoid it?
The law of unintended consequences plays a role. We should of course be aware of
why drug users have begun candyflipping in the first place, which is generally to achieve a more potent intoxicating experience than was achieved on the dose of MDMA in the first place. I suspect that when faced with the claim that LSD potentiates MDMA-derived neurotoxicity users may simply consume more MDMA at a time when they would have been candyflipping, and the result may actually be worse. In reality, the effect from LSD appears to be small, requires very large doses of LSD to occur, and is probably much smaller than the risk of a higher dose of MDMA.
Having read the study, it still seems to me that, for example, taking 100 mg MDMA + 100 µg LSD is safer than taking 150 mg MDMA. Your conclusions may vary. Obviously it would be better to caution people against seeking strong drug experiences, especially those involving MDMA, entirely. Unfortunately, this is rather hard to do.